New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management-Reference-Cited by-同舟云学术

New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management

Published:2014-06 Issue:6 Volume:44 Page:525-536
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Tran H.¹,Joseph J.²,Young L.³,McRae S.⁴,Curnow J.⁵,Nandurkar H.⁶,Wood P.⁷,McLintock C.⁸

Affiliation:

1. Haemostasis Thrombosis Unit; The Alfred Hospital; Melbourne Victoria Australia

2. Haematology Department; St Vincent's Hospital; Sydney New South Wales Australia

3. Clinical Haematology; Auckland City Hospital; Auckland Australia

4. Haemophilia Treatment Centre, SA Pathology; Royal Adelaide Hospital; Adelaide South Australia

5. Haematology Department; Concord Hospital; Sydney New South Wales Australia

6. Haematology Department; Melbourne University; Melbourne Victoria Australia

7. Pathology Queensland; Princess Alexandra Hospital; Brisbane Queensland Australia

8. Obstetric Medicine, National Women's Health; Auckland City Hospital; Auckland New Zealand

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imj.12448/fullpdf

Reference43 articles.

1. Boehringer Ingelheim PRADAXA® (dabigatran etexilate mesylate) capsules for oral use Initial U.S. Approval: 2010 2012 http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022512s009lbl.pdf

2. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

3. Janssen Research and Development Application number: 022406orig1s000. Clinical pharmacology and biopharmaceutics review(s) 2011 http://accessdata.fda.gov/drugsatfda_docs/nda/2011/022406Orig1s000ClinPharmR.pdf

4. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

5. Bristol Myers Squibb ELIQUIS (apixaban) tablets for oral use Initial U.S. Approval: 2012 2012 http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202155s000lbl.pdf

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct oral anticoagulants or vitamin K antagonists in emergencies: comparison of management in an observational study;Research and Practice in Thrombosis and Haemostasis;2023-07

2. Risk of Bleeding in Liver Cirrhosis Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-analysis;Thrombosis and Haemostasis;2023-06-19

3. Functional outcomes of patients with ischaemic stroke with known atrial fibrillation not on therapeutic anticoagulation;Internal Medicine Journal;2023-03-20

4. Thrombin generation in real life bleeding patients on oral anticoagulants reversed (or not) with (activated) prothrombin complex concentrate;Thrombosis Research;2023-03

5. A Review on the Green Synthesis of Benzimidazole Derivatives and Their Pharmacological Activities;Catalysts;2023-02-11